Scientists probe mystery rash with common allergy drug
NCT ID NCT06012448
Summary
This small, completed study aimed to understand how a drug called dupilumab works in people with a chronic, unexplained skin rash. Researchers gave 10 participants injections of dupilumab to see how it changed their immune cells and if it reduced the rash and itching. The main goal was to learn more about the biology of the rash, not primarily to prove the drug's effectiveness as a treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMAL HYPERSENSITIVITY REACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.